Ratings for Omega Therapeutics (NASDAQ:OMGA) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $9.83, with a high estimate of $12.00 and a low estimate of $7.00. This current average has decreased by 4.1% from the previous average price target of $10.25.
Understanding Analyst Ratings: A Comprehensive Breakdown
The standing of Omega Therapeutics among financial experts becomes clear with a...
Ratings for Omega Therapeutics (NASDAQ:OMGA) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
過去三個月，有 6 位分析師對 Omega Therapeutics (納斯達克股票代碼：OMGA) 進行了評級，展示了看好和看淡的觀點混合。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
總結他們最近的評估，下表展示了過去30天內不斷變化的情緒，並將其與之前的幾個月進行了比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $9.83, with a high estimate of $12.00 and a low estimate of $7.00. This current average has decreased by 4.1% from the previous average price target of $10.25.
Understanding Analyst Ratings: A Comprehensive Breakdown
The standing of Omega Therapeutics among financial experts becomes clear with a...
